17
Backers in a recent round
13 added at least one new company in this market. The remainder participated only in companies they had already backed here.
Explore recently active backers ↗MARKET NOTES / 001UNITED STATES / BOSTON / BIOPHARMA OUTSOURCING
LESS GUESSWORK. A BETTER RESEARCH LIST.Biopharma Outsourcing.
Biopharma Outsourcing.
Boston.
Map the capital.
Find your next conversation.
Who backs this market, where they enter, and how recently they have added a new company. A directory built around the questions founders actually ask.
Build your research shortlist ↘Companies are based in Boston · investors can be based anywhere
Dataset through 22 May 2026 · calculated 14 Sep 2026
01 / THE SHORTLIST LAB
Make the list work for your company.
2 backers based in Boston are shown by default. Compare up to three.
A CLOSER LOOK AT WHERE
Find investors in your preferred location.
Search a recorded city, country or neighbourhood among the backers of this market.
Five location searches per day. Results use recorded locations; some investors have city-level coverage only.
2 of 18 selected backers · Boston only
Shows investors whose recorded city is Boston. Unknown cities are excluded. Market charts cover all investor locations.
Theme filtering selects backers of companies carrying that theme tag. Entry-stage filtering selects backers with an entry at that stage; the two matches may be different companies. Row metrics describe their entire dated Biopharma Outsourcing history in Boston.
Your side-by-side comparison
Lead flags and later investments may be incompletely recorded. Repeat counts are not adjusted for time since entry.
| Compare | Investor / recorded location | Companies here | New in 24 months | Median total entry round | Companies backed again | Latest investment |
|---|---|---|---|---|---|---|
| Loading investors… | ||||||
No backers match these filters. Broaden the theme, location, entry stage or activity window.
02 / THE MARKET READActivity is a better starting point
Activity is a better starting point
than a long list of names.
Latest 24 months: after 22 May 2024 through 22 May 2026.
4
Distinct equity rounds
Across 3 companies, versus 3 rounds in the preceding 24 months. Each company round is counted once.
See the recent evidence ↗50%
Rounds at Angel, Pre-Seed or Seed
2 of 4 recent rounds. Compare your stage with its own financing range before sizing the ask.
Compare stage ranges ↗65%
Participations were first entries
13 first investor–company relationships out of 20 participations. The other 7 were later rounds together.
Find backers adding companies ↗Build a syndicate beyond the city.
Of 17 recently active backers, 2 have a recorded Boston location and 14 are based elsewhere. Location is missing for 1. Search by market experience first, then investigate the people and their remit.
Match the whole round to your plan.
Recent Seed rounds have a median size of $6.5M, across 1 disclosed amounts. That is total company financing. An individual investor’s cheque or available capital is not disclosed here.
04 / THE DEPTH MAP
One appearance, or a pattern?
45 of 48 backers with dated histories appear in just one company. Select a cell to explore the directory.
| Portfolio breadth here | 1 company | 2 companies | 3–5 | 6–10 | 11+ |
|---|---|---|---|---|---|
| Firms & institutions | |||||
| Individual angels |
Circle area increases with backer count. The shortlist includes backers with 2 or more companies in this market, plus other backers active in the latest 24 months. In the 1-company cell, only recently active backers are available to explore. The shortlist’s investor-location filter also applies; select all locations to broaden the results. 0 backers have only undated entries.
05 / ROUND DESIGN
Different stages. Different capital.
Recent equity rounds · 24-month window.
Amounts are in USD.
StageDistinct roundsMedian / middle half
Seed
2
$6.5M$6.5M–$6.5M1 disclosed · small sample
Series A
2
$66M$38M–$93M2 disclosed · small sample
06 / FOLLOW THE EVIDENCE
The most recent recorded rounds.
Distinct company rounds.
Named backers are shown lead-first.
Biotechnology company developing treatments for autoimmune and inflammatory disorders using antibody-drug conjugates
Undisclosed total equity round4 named backers
5AM Ventures · Arch Venture Partners · Atlas Venture · Sanofi Ventures
Provider of automated bioanalysis platform for accelerated clinical drug development
$11M total equity round6 named backers
The Aligned Fund · Cybernetix Ventures · Drive Capital · Freestyle · Life Extension Ventures · +1 more
Provider of automated bioanalysis platform for accelerated clinical drug development
$6.5M total equity round3 named backers
Freestyle · Life Extension Ventures · Swift Ventures
Generative biological and chemical company focused on drug discovery
$120M total equity round7 named backers
RA Capital Management · Catalio Capital Management · Cooley · Gaingels · Insight Partners · +2 more
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
$245M total equity round5 named backers
Atlas Venture · Bain Capital Life Sciences · Forbion · Sofinnova Investments · RA Capital Management
Generative biological and chemical company focused on drug discovery
$33M total equity round4 named backers
RA Capital Management · Gaingels · Insight Partners · NVIDIA
07 / READING THE ATLAS
What these patterns can tell you.
The market boundary
Recorded equity rounds for companies tagged Biopharma Outsourcing and located in Boston. Investor headquarters may be elsewhere. Company sector and location reflect the available company records, not necessarily the location or sector at the investment date.
The time boundary
Data coverage ends 22 May 2026. The latest market round is 19 Nov 2025. There are 0 undated participations, excluded from timing metrics. Activity after the cutoff is unknown.
The relationship boundary
“New” is the first dated relationship between a backer and a company in this market. “Backed again” requires a later dated round together. A first observed entry may follow an earlier unrecorded investment.
The financing boundary
Amounts describe entire equity rounds, not personal cheques, fund capacity or returns. Medians exclude missing and non-positive amounts; the middle half spans the 25th–75th percentiles. A recorded investment does not establish current availability.
Find the businesses
worth a closer look.
Search Boston Biopharma Outsourcing companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗A research dashboard.
Built for your company.
We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Turn your questions
into deeper research.
Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.Calculated 14 Sep 2026 · 18 investor histories to explore